Tirzepatide Peptide Injection 6mg Vial - Cas No: 2461524-54-7

Key Features :-
Contains 6 mg tirzepatide per vial
Synthetic peptide formulation
Supports diabetes and weight management research
Injectable for accurate dosing
High-purity pharmaceutical grade
Designed for clinical or research use
Promotes glucose and metabolic regulation
Sterile and ready-to-use vial
Stable under recommended storage conditions
Administered under professional supervision
Tirzepatide is a synthetic peptide engineered to act as a dual receptor agonist, targeting both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) pathways. Due to its dual-pathway activity, Tirzepatide is of significant interest in advanced metabolic, endocrine, and peptide-based research.
Manufactured to high-purity specifications, Tirzepatide is supplied as a lyophilized peptide to ensure enhanced stability, consistency, and long-term storage under appropriate laboratory conditions. Its molecular structure is optimized to support controlled research involving metabolic signaling, receptor interactions, and peptide innovation.